In light of the many important functions of the imidazole ring, it is not surprising that many of the ring-fluorinated analogues proved to have quite interesting biological properties. 2-Fluorohistidine is a notable example, showing a range of activities that may or may not be related to the ability of this analogue to be incorporated into protein in vivo. We recently have re-initiated efforts to define the mechanisms by which this analogue exerts its effects.? ? Fluorohistidine:? ? Biochemical Incorporation of Fluorohistidine into Proteins.? ? Work is continuing in a collaborative project on incorporation of 2-fluoro-L-hisitidine into anthrax protein as a tool to study details of the mechanism of toxicity. The pathogenesis of Bacillus anthracis relies in part upon a pH dependent conversion of the anthrax protective antigen (PA) from a heptameric prepore to a pore. Lowering the pH in vitro from 8 to 7 can induce pore formation by protective antigen. However, a pH of 6 is required in vivo in the presence of the receptor to induce pore formation and dissociation from the receptor. The pH dependence of pore formation in the presence of the anthrax ANTXR2 receptor is consistent for the titration of His residues. There are several His residues in the domain of PA63 critical for pore formation as well as a His residue on CMG2. Thus, protonation of His in ANTXR2 andor PA and subsequent conformational changes have been suggested as critical events in pore formation. To investigate this,2FHis has been incorporated into both the receptor (ANTXR2) and PA83. Since the imidazole pKa of 2FHis is about 1, protonation of 2FHis will not occur under the pH changes that lead to pore formation. This will allow determination of the importance of His protonation in anthrax infectivity. ? ? As reported previously, the presence of 2FHis in the anthrax receptor ANTXR2 had no effect on pore formation mediated by native PA. Thus, the proposal that a CMG2-His protonation repels an Arg in PA63 causing conformational changes that lead to pore formation appears unlikely. Since 2FHis-ANTXR2 possesses only a single resonance in the 19F NMR spectrum (there is only one histidine in ANTXR2), this signal allowed us to monitor association-dissociation to PA as a function of pH using 19F-NMR. In these experiments, 2FHis-ANTXR2 is added to (PA63)7, resulting in a significant decrease in the intensity of the 2-FHis resonance, presumably from the slower tumbling motion of the complex. As the pH is lowered to 5, an increase in the intensity of the fluorine resonance occurs, indicating that ANTXR2 dissociates from PA upon formation of the transmembrane pore. These data are consistent with of others, and provide the first direct evidence that dissociation of the receptor occurs upon pore formation. ? ? In addition, the pH for pre-pore to pore conversion was not altered for 2FHis-labelled PA in the absence of receptor. However, pore formation by 2FHis-labelled PA from heptameric pre-pore (2-FHis PA63)7, in the presence of the receptor was blocked. In addition, translocation experiments show that pores formed from (2-FHis PA63)7, in the absence of receptor are unable to translocate LF. In addition, 2FHis PA is unable to mediate cell death in vivo. From these results it seems likely that protonation of residues in PA causes conformational changes that lead to pore formation and that binding to the receptor inhibits these changes. The mechanism by which ANTXR2 blocks pore formation mediated by 2FHis PA is not obvious. One possibility is that 2FHis PA forms a more stable complex with the receptor, thus blocking the dissociation that accompanies heptamer formation and pore formation. It also is not clear why pores that are formed in the absence of receptor protein are unable to translocate lethal factor. Work in progress is designed to identify the critical His residues in these processes.? ? NMR measurements using 2-FHis121-ANTXR2 have recently provided direct evidence that protonation events in the protective antigen prepore result in dissociation from the anthrax toxin receptor at acidic pH. ? ? Synthesis of 2-FHis and 4-FHis containing analogs of carnosine? ? The dipeptide carnosine (beta-alanyl-His) has many important biological functions, including a possible role in the regulation of blood glucose through control of autnonomic nerves. We have embarked on a project to prepare carnosine derivatives wherein histidine is replaced with 2-FHis or 4-FHis. Normal amide bond forming procedures were used to to prepare the dipeptides from beta-alanine and 2- and 4-FHis. Future plans include evaluation of these new analogues in carnosine utilizing systems.

Project Start
Project End
Budget Start
Budget End
Support Year
32
Fiscal Year
2008
Total Cost
$413,936
Indirect Cost
City
State
Country
United States
Zip Code
Hajduch, Jan; Nam, Ghilsoo; Kim, Eun Ju et al. (2008) A convenient synthesis of the C-1-phosphonate analogue of UDP-GlcNAc and its evaluation as an inhibitor of O-linked GlcNAc transferase (OGT). Carbohydr Res 343:189-95
Hajduch, Jan; Cramer, John C; Kirk, Kenneth L (2008) An Enantioselective Synthesis of (S)-4-Fluorohistidine. J Fluor Chem 129:807-810
Hajduch, Jan; Dolensky, Bohumil; Yoshida, Shinichi et al. (2008) Synthesis of (E)- and (Z)-alpha,beta-Difluorourocanic Acid. J Fluor Chem 129:112-118
Fujiwara, Tomoya; Yin, Bin; Jin, Meixiang et al. (2008) Synthetic Studies of 3-(3-Fluorooxindol-3-yl)-l-alanine. J Fluor Chem 129:829-835
Heredia-Moya, Jorge; Kirk, Kenneth L (2007) Photochemical Schiemann Reaction in Ionic Liquids. J Fluor Chem 128:674-678
Wimalasena, D Shyamali; Cramer, John C; Janowiak, Blythe E et al. (2007) Effect of 2-fluorohistidine labeling of the anthrax protective antigen on stability, pore formation, and translocation. Biochemistry 46:14928-36
Nagasawa, Hideko; Uto, Yoshihiro; Kirk, Kenneth Lee et al. (2006) Design of hypoxia-targeting drugs as new cancer chemotherapeutics. Biol Pharm Bull 29:2335-42
Uto, Yoshihiro; Ae, Shutaro; Koyama, Daisuke et al. (2006) Artepillin C isoprenomics: design and synthesis of artepillin C isoprene analogues as lipid peroxidation inhibitor having low mitochondrial toxicity. Bioorg Med Chem 14:5721-8
Kirk, Kenneth L (2006) Selective fluorination in drug design and development: an overview of biochemical rationales. Curr Top Med Chem 6:1447-56
Eichler, Jack F; Cramer, John C; Kirk, Kenneth L et al. (2005) Biosynthetic incorporation of fluorohistidine into proteins in E. coli: a new probe of macromolecular structure. Chembiochem 6:2170-3

Showing the most recent 10 out of 33 publications